InspireMD Inc

NASDAQ:NSPRUnited States

InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

Contact Information

Headquarters

4 Menorat Hamaor St.TEL AVIV-YAFO, Israel 6744832

Phone

857-453-6553

Fax

302-655-5049

Executives

Independent Chairman of the Board

Paul Stuka

President, Chief Executive Officer, Director

Marvin Slosman

Chief Financial Officer, Treasurer, Company Secretary

Craig Shore

Chief Operating Officer

Andrea Tommasoli

Vice President - Finance, Human Resources

Amir Kohen